Article Information
History
- March 14, 2021.
Article Versions
- Version 1 (January 2, 2021 - 22:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andrea Pilotto, MD1,2,*,
- Viviana Cristillo, MD1,
- Stefano Cotti Piccinelli, MD1,
- Nicola Zoppi, MD1,
- Giulio Bonzi1,
- Davide Sattin, PSYD2,
- Silvia Schiavolin, PSY2,
- Alberto Raggi, PhD2,
- Antonio Canale3,
- Stefano Gipponi, MD1,
- Ilenia Libri, MD1,
- Martina Frigerio1,
- Michela Bezzi, MD4,
- Matilde Leonardi, MD2 and
- Alessandro Padovani, MD, PhD1
- 1Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy
- 2Neurology, Public Health Disability Unit – Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 3Department of Statistics, University of Padova, Padova, Italy
- 4Respiratory Unit, ASST Spedali Civili di Brescia, Brescia, Italy
- ↵*Corresponding authors:
Andrea Pilotto and Alessandro Padovani, Neurology Unit, Department of Clinical and Experimental Sciences P.le Spedali Civili 1, 25123, Brescia, Italy Phone: 0039 0303995632 Email: pilottoandreae{at}gmail.com; alessandro.padovani{at}unibs.it;
AUTHOR CONTIRBUTION Conception and design of the study: AP, VC, ML, DS and AP. Acquisition and analysis of data: AP, VC, SCP, NZ, GB, AC, SG, IL, DC, MF, MB and AP. Drafting the manuscript and figures: AP, VC, GB and AP.
Posted March 14, 2021.
Long-term neurological manifestations of COVID-19: prevalence and predictive factors
